The Patent Finder
US

BETA-L-2'-Deoxy-NUCLEOSIDES for the Treatment of Hepatitis B

US 6,946,450 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Aug 10, 2019 · Medium confidence

Held by Novartis AG
Filed May 13, 2003 as application 10/437,802 · Granted Sep 20, 2005
Base term, 20 years from filing
Today
20 years from filing
Term ended Aug 10, 2019
1999 2026
Clock starts
Aug 10, 1999
Term ended
Aug 10, 2019
Granted
Sep 20, 2005
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 6,566,344, US 6,569,837, to Aug 10, 2019. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
52
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 10, 1999, when application 09/371,747, the earliest non-provisional in its chain, was filed (this one was filed May 13, 2003); a parent in its chain could not be resolved (the next row)Aug 10, 2019High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 6,566,344, US 6,569,837)resolves to Aug 10, 2019, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderAug 10, 2019Medium confidence

This family

US 6,596,700Lapsed on the fee record
Jul 2011
Jul 2011
US 6,566,344Term ended
Aug 2019
Aug 2019
US 6,569,837Term ended
no later than Oct 2020
no later than Oct 2020
US 6,787,526Lapsed on the fee record
Sep 2012
Sep 2012
US 6,946,450this patent
Aug 2019
Aug 2019
US 7,608,600In force
no later than Sep 2028
no later than Sep 2028
US 7,662,798Lapsed on the fee record
Feb 2022
Feb 2022
Application 11/005,440Abandoned
not computed
not computed
8 of 52 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 26, 2014
Reel 32535, frame 402
Idenix Pharmaceuticals, Inc.Novartis AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited